Ciprofloxacin in vitro activity alone and in combination against clinical isolates of glucose nonfermenting bacteria.
Marklein
G
G
Institute for Medical Microbiology and Immunology, University of Bonn, Federal Republic of Germany.
Lotze
G
G
Ungerechts
J
J
D016954:Acinetobacter calcoaceticus / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002939:Ciprofloxacin / Q000494:pharmacology*; D004338:Drug Combinations; D005285:Fermentation; D005947:Glucose / Q000378:metabolism; D008826:Microbial Sensitivity Tests; D011549:Pseudomonas / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D011550:Pseudomonas aeruginosa / Q000166:cytology / Q000187:drug effects / Q000378:metabolism
D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D002939:Ciprofloxacin; D005947:Glucose